Alfred Psychiatry, Alfred Health, Melbourne, Australia.
RMIT University School of Health and Biomedical Sciences, Melbourne, Australia.
Int J Ment Health Nurs. 2016 Apr;25(2):151-8. doi: 10.1111/inm.12215. Epub 2016 Feb 1.
Co-occurring mental illness and substance use disorder, known as dual diagnosis, is a significant challenge to mental health services. Few older adult specific alcohol and other drug treatment services exist, meaning older adult mental health services may become the default treatment option for many. Evidence suggests that dual diagnosis leads to substandard treatment outcomes, including higher rates of psychiatric relapse, higher costs of care and poorer treatment engagement. This paper explores the prevalence of co-occurring alcohol and other drug (AOD) use in an older adult community mental health service in inner Melbourne, Australia. This aim was accomplished by using a retrospective file audit of clinical intake assessments (n = 593) performed on consumers presenting to the service over a two-year period, June 2012-2014. Of consumers presenting to the service, 15.5% (n = 92) were assessed by clinicians as having co-occurring AOD use. Depression predominated in the dual diagnosis group as the primary mental health disorder. Dual diagnosis consumers in this sample were statistically more likely to be male and younger than their non-dual diagnosis counterparts. A limitation of this audit was the lack of implementation of screening tools, leaving assessment to clinical judgement or the interest of the clinician. This may also explain the discrepancy between the results of this study and previous work. Although appearing to be a relatively small percentage of assessments, the results accounted for 92 individuals with complex mental health, AOD and medical issues. Poor screening procedures in a population that is traditionally difficult to assess need to be rectified to meet the future challenges inherent in the ageing baby boomer generation, changing drug use trends and extended lifespans through harm reduction initiatives and medical advancements.
共病精神疾病和物质使用障碍,称为双重诊断,是精神卫生服务面临的重大挑战。很少有专门针对老年人群的酒精和其他药物治疗服务,这意味着许多老年精神卫生服务可能成为默认的治疗选择。有证据表明,双重诊断会导致治疗效果不佳,包括精神疾病复发率更高、护理费用更高和治疗参与度更差。本文探讨了澳大利亚墨尔本内城区一家老年社区精神卫生服务机构中同时存在酒精和其他药物(AOD)使用的流行情况。这一目的是通过对在两年内(2012 年 6 月至 2014 年)向该服务机构就诊的消费者进行临床摄入评估(n = 593)的回顾性档案审计来实现的。在向该服务机构就诊的消费者中,有 15.5%(n = 92)被临床医生评估为同时存在 AOD 使用。在双重诊断组中,抑郁是主要的精神健康障碍。在这个样本中,双重诊断消费者在统计学上更可能是男性且比非双重诊断消费者年轻。本次审计的一个局限性是缺乏实施筛选工具,使评估依赖于临床判断或临床医生的兴趣。这也可能解释了本研究结果与以往工作之间的差异。尽管看起来是评估中的一个相对较小的百分比,但这些结果涉及 92 名患有复杂精神健康、AOD 和医疗问题的个体。在一个传统上难以评估的人群中,需要纠正不良的筛选程序,以应对老龄化婴儿潮一代、药物使用趋势变化、通过减少伤害倡议和医疗进步延长寿命所带来的未来挑战。